Gapping down
In reaction to earnings/guidance:
- X -0.8% (guidance)
Other news:
- ACLX -12.6% (announces clinical hold for its iMMagine-1 Phase 2 Clinical Program)
- PHVS -5% (entered into a subscription agreement relating to the offer and sale of an aggregate of 6,951,340 ordinary shares of the Company)
- RYTM -3% (Presents Data Demonstrating BMI Reduction in Patients with Hypothalamic Obesity Treated with Setmelanotide over Six Months at ENDO 2023)
- DDD -2.6% (updates its shareholders on its proposal for Stratasys (SSYS))
- BABA -2.4% (announces Chairman and CEO succession plan)
- BEEM -2.4% (acquires Amiga; provides guidance; prices 2.5 mln shares of common stock at $9.00 per share)
- ATI -2% (secures estimated $1.2 billion in aerospace and defense sales commitments)
- FUSN -1.3% (files for 4,784,689 share common stock offering by selling shareholders)
Analyst comments:
- PFGC -1.1% (downgraded to Equal-Weight from Overweight at Morgan Stanley)